Amino Acid Usage Patterns in Daily Practice
An Observational Study to Evaluate Amino Acid Usage Patterns in Daily Practice
1 other identifier
observational
354
1 country
18
Brief Summary
The present study aims to evaluate the patient profile including medical conditions who use a nutritional supplement along with a balanced and varied diet in Turkey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2012
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 24, 2014
CompletedFirst Posted
Study publicly available on registry
May 26, 2014
CompletedMay 26, 2014
May 1, 2014
1.2 years
April 24, 2014
May 21, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Frequencies of Medical Conditions
Diagnosis information
Baseline
Secondary Outcomes (3)
Intake of Amino Acid containing Nutrition Supplement
Baseline and Week 8
Anthropometrics
Change from Baseline to Week 8
Laboratory Parameters
Change from Baseline to Week 8
Study Arms (1)
Group Receiving Supplement
Amino acid supplement group
Interventions
Eligibility Criteria
Subjects receiving amino acid supplement prior to enrollment
You may qualify if:
- Age ≥ 18 years old.
- Consuming amino acid containing oral nutritional supplement before enrolment for malnutrition for hard-to-heal wounds or malnutrition due to primary disease.
- Followed by internal medicine or surgery departments.
You may not qualify if:
- History of allergy or hypersensitive reaction to any ingredient in the amino acid containing oral nutritional supplement.
- History of any food allergy or intolerance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (18)
Adana Numune Eğitim ve Araştırma Hastanesi
Adana, Turkey (Türkiye)
Çukurova Üniversitesi Tıp Fakültesi
Adana, Turkey (Türkiye)
ANKARA ATATÜRK Eğitim ve Araştırma Hastanesi
Ankara, Turkey (Türkiye)
Ankara Numune Eğitim ve Araştırma Hastanesi
Ankara, Turkey (Türkiye)
Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi
Ankara, Turkey (Türkiye)
Gazi Üniversitesi Tıp Fakültesi
Ankara, Turkey (Türkiye)
Bursa Çekirge Devlet Hastanesi
Bursa, Turkey (Türkiye)
Uludağ Üniversitesi Tıp Fakültesi
Bursa, Turkey (Türkiye)
Acıbadem Eskişehir Hospital
Eskişehir, Turkey (Türkiye)
Fatih Sultan Mehmet Eğitim ve Araştırma Hastanesi
Istanbul, Turkey (Türkiye)
GÜLHANE ASKERİ TIP AKADEMİSİ - İstanbul
Istanbul, Turkey (Türkiye)
İstanbul Üniversitesi İstanbul Tıp Fakültesi
Istanbul, Turkey (Türkiye)
T.C.Bezmiâlem Vakıf Üniversitesi Tıp Fakültesi Hastanesi
Istanbul, Turkey (Türkiye)
Dr. Suat Seren Gogus Hastaliklari Hastanesi
Izmir, Turkey (Türkiye)
Ege Üniversitesi Tıp Fakültesi
Izmir, Turkey (Türkiye)
Erciyes Üniversitesi Tıp Fakültesi
Kayseri, Turkey (Türkiye)
Ondokuz Mayıs Üniversitesi Tıp Fakültesi
Samsun, Turkey (Türkiye)
Karadeniz Teknik Üniversitesi Tıp Fakültesi
Trabzon, Turkey (Türkiye)
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Tahsin Ozcagli, MD
Abbott Nutrition Turkey
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2014
First Posted
May 26, 2014
Study Start
December 1, 2012
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
May 26, 2014
Record last verified: 2014-05